The No Red Tape for Addiction Treatment Act would require state Medicaid programs to cover at least one formulation of each FDA-approved medication for opioid use disorder without prior authorization, helping prevent dangerous delays in care.
Descubra los peligros del Kratom 7-OH, un potente compuesto similar a los opioides hasta 13 veces más fuerte que la morfina. Aprenda sobre los riesgos de adicción, efectos secundarios y cómo mantenerse seguro. Incluye advertencias de la FDA.
The opioid settlement funds present a key opportunity for communities to address the current opioid epidemic and prevent future addiction crises. This report aims to help guide decision-makers in using the funds to strengthen substance use prevention, reduce risk factors, and promote long-term well-being.
Nos enfocamos en prevenir y tratar los trastornos por consumo de sustancias, brindando a familias, comunidades y profesionales de la salud conocimientos prácticos y confiables para que apoyen a los jóvenes en riesgo o que enfrentan adicción.
Partnership to End Addiction joined 15 other leading behavioral health organizations in applauding new rules to strengthen the enforcement of the Parity Act.
Besides recreational use, some early studies and personal reports or personal stories and experiences suggest that 5-MeO-DMT might help with anxiety, depression, and PTSD. However, further research is needed to know if it’s safe and effective, as it has been linked to deaths
Ibogaine is a natural substance found in the root of a plant that grows in West Africa. In small amounts, ibogaine works as a mild stimulant, and people have been using it for a long time to fight tiredness, hunger, and thirst. When taken in larger amounts, it can create strong mind-altering experiences.
As the nation moves toward widescale legalization of marijuana, and possibly other psychoactive and potentially addictive substances, it is important to ensure that the regulatory environment around such legalization makes protecting young people a priority.
This website uses cookies. We use cookies and similar technologies to give
you the best experience. By using this website, you accept our Privacy Policy and Terms of Use.
